Cyclo Therapeutics CYTHW Stock
Cyclo Therapeutics Price Chart
Cyclo Therapeutics CYTHW Financial and Trading Overview
| Cyclo Therapeutics stock price | 0.03 USD |
| Previous Close | 0.03 USD |
| Open | 0.07 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.03 - 0.03 USD |
| 52 Week Range | 0.03 - 0.61 USD |
| Volume | 28.41K USD |
| Avg. Volume | 12.32K USD |
| Market Cap | N/A |
| Beta (5Y Monthly) | -0.566 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CYTHW Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Cyclo Therapeutics Stock Price History
| Beta (5Y Monthly) | -0.566 |
| 52-Week Change | -86.55% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 0.61 USD |
| 52 Week Low | 0.03 USD |
| 50-Day Moving Average | 0.23 USD |
| 200-Day Moving Average | 0.18 USD |
CYTHW Share Statistics
| Avg. Volume (3 month) | 12.32K USD |
| Avg. Daily Volume (10-Days) | 5.74K USD |
| Shares Outstanding | N/A |
| Float | 11.51M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3545.95% |
| Gross Margin | 91.24% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -284.27% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 870.73K USD |
| Revenue Per Share (ttm) | 0.03 USD |
| Quarterly Revenue Growth (yoy) | -52.80% |
| Gross Profit (ttm) | 794.48K USD |
| EBITDA | -24665556 USD |
| Net Income Avi to Common (ttm) | -24799670 USD |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 928.01K USD |
| Total Cash Per Share (mrq) | 0.03 USD |
| Total Debt (mrq) | 12.21M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.174 |
| Book Value Per Share (mrq) | -0.468 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -22517552 USD |
| Levered Free Cash Flow (ttm) | -13049121 USD |
Profile of Cyclo Therapeutics
| Country | United States |
| State | FL |
| City | Gainesville |
| Address | 6714 NW 16th Street |
| ZIP | 32653 |
| Phone | 386 418 8060 |
| Website | https://cyclotherapeutics.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 8 |
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, engages in the development of cyclodextrin-based products for the treatment of neurodegenerative diseases. The company's lead drug candidate is Trappsol Cyclo (hydroxypropyl beta cyclodextrin), an orphan drug, which is in Phase III clinical trials for the treatment of Niemann-Pick Type C disease; and in Phase IIb clinical trials for the treatment of Alzheimer's disease. It also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is headquartered in Gainesville, Florida. Cyclo Therapeutics, Inc. is a subsidiary of Rafael Holdings, Inc.
Q&A For Cyclo Therapeutics Stock
What is a current CYTHW stock price?
Cyclo Therapeutics CYTHW stock price today per share is 0.03 USD.
How to purchase Cyclo Therapeutics stock?
You can buy CYTHW shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cyclo Therapeutics?
The stock symbol or ticker of Cyclo Therapeutics is CYTHW.
Which industry does the Cyclo Therapeutics company belong to?
The Cyclo Therapeutics industry is Drug Manufacturers - Specialty & Generic.
How many shares does Cyclo Therapeutics have in circulation?
The max supply of Cyclo Therapeutics shares is 0.
What is Cyclo Therapeutics Price to Earnings Ratio (PE Ratio)?
Cyclo Therapeutics PE Ratio is now.
What was Cyclo Therapeutics earnings per share over the trailing 12 months (TTM)?
Cyclo Therapeutics EPS is 0 USD over the trailing 12 months.
Which sector does the Cyclo Therapeutics company belong to?
The Cyclo Therapeutics sector is Healthcare.